Literature DB >> 28976629

Leptomeningeal melanoma-A case series in the era of modern systemic therapy.

Malmaruha Arasaratnam1, Angela Hong2,3,4, Brindha Shivalingam2,4,5, Helen Wheeler1, Alexander D Guminksi1,2,4, Georgina V Long1,2,4, Alexander M Menzies1,2,4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28976629     DOI： 10.1111/pcmr.12652

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  9 in total

1.  Pericyte Ontogeny: The Use of Chimeras to Track a Cell Lineage of Diverse Germ Line Origins.

Authors:  Heather C Etchevers
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Leptomeningeal Metastases: New Opportunities in the Modern Era.

Authors:  Jessica A Wilcox; Min Jun Li; Adrienne A Boire
Journal:  Neurotherapeutics       Date:  2022-07-05       Impact factor: 7.620

Review 3.  Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted Agents.

Authors:  Stergios J Moschos
Journal:  Am J Clin Dermatol       Date:  2022-05-09       Impact factor: 6.233

Review 4.  Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.

Authors:  Yolanda Piña; Sirisha Yadugiri; Debra N Yeboa; Sherise D Ferguson; Peter A Forsyth; Isabella C Glitza Oliva
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

5.  Radiotherapy in Leptomeningeal Disease: A Systematic Review of Randomized and Non-randomized Trials.

Authors:  Samantha M Buszek; Caroline Chung
Journal:  Front Oncol       Date:  2019-11-15       Impact factor: 6.244

6.  Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases.

Authors:  Pauline Tétu; Lila Sirven-Villaros; Stefania Cuzzubbo; Renata Ursu; Barouyr Baroudjian; Julie Delyon; François Nataf; Constance De Margerie-Mellon; Clara Allayous; Wendy Lefevre; Antoine F Carpentier; Céleste Lebbé
Journal:  Cancers (Basel)       Date:  2020-09-16       Impact factor: 6.639

7.  Case Report: Differential Genomics and Evolution of a Meningeal Melanoma Treated With Ipilimumab and Nivolumab.

Authors:  Remberto Burgos; Andrés F Cardona; Nicolas Santoyo; Alejandro Ruiz-Patiño; Juanita Cure-Casilimas; Leonardo Rojas; Luisa Ricaurte; Álvaro Muñoz; Juan Esteban Garcia-Robledo; Camila Ordoñez; Carolina Sotelo; July Rodríguez; Zyanya Lucia Zatarain-Barrón; Diego Pineda; Oscar Arrieta
Journal:  Front Oncol       Date:  2022-01-05       Impact factor: 6.244

Review 8.  Challenges and Advances in Diagnosis and Treatment of Leptomeningeal Disease (LMD).

Authors:  Sherise D Ferguson; Elena I Fomchenko; Renato A Guerrieri; Isabella C Glitza Oliva
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

Review 9.  Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations-Chances and Challenges.

Authors:  Marvin Kuske; Ricarda Rauschenberg; Marlene Garzarolli; Michelle Meredyth-Stewart; Stefan Beissert; Esther G C Troost; Oliva Isabella Claudia Glitza; Friedegund Meier
Journal:  Am J Clin Dermatol       Date:  2018-08       Impact factor: 7.403
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.